iShares Neuroscience and Healthcare ETF (IBRN)

Assets	$3.35M
Expense Ratio	0.47%
PE Ratio	15.61
Shares Out	150,000
Dividend (ttm)	$0.10
Dividend Yield	0.45%
Ex-Dividend Date	Dec 17, 2024
Payout Frequency	Annual
Payout Ratio	7.06%

Volume	152
Open	22.34
Previous Close	22.36
Day's Range	22.34 - 22.34
52-Week Low	17.86
52-Week High	28.74
Beta	0.70
Holdings	62
Inception Date	Aug 24, 2022

About IBRN

Fund Home Page

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is issued by BlackRock.

• Asset Class: Equity
• Category: Health
• Region: Global
• Stock Exchange: NYSEARCA
• Ticker Symbol: IBRN
• ETF Provider: BlackRock
• Index Tracked: NYSE FactSet Global Neuro Biopharma and MedTech Index

Top 10 Holdings

42.52% of assets

Name	Symbol	Weight
Scholar Rock Holding Corporation	SRRK	4.51%
Xenon Pharmaceuticals Inc.	XENE	4.49%
SK Biopharmaceuticals Co., Ltd.	326030	4.43%
Neurocrine Biosciences, Inc.	NBIX	4.40%
Biogen Inc.	BIIB	4.27%
Denali Therapeutics Inc.	DNLI	4.27%
ACADIA Pharmaceuticals Inc.	ACAD	4.07%
Supernus Pharmaceuticals, Inc.	SUPN	4.06%
PTC Therapeutics, Inc.	PTCT	4.04%
argenx SE	ARGX	3.97%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 17, 2024	$0.10114	Dec 20, 2024
Dec 20, 2023	$0.0063	Dec 27, 2023
Jun 7, 2023	$0.00824	Jun 13, 2023

Performance

IBRN had a total return of -4.18% in the past year, including dividends. Since the fund's inception, the average annual return has been -4.09%.